CV Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Mar. 31, 2024	Sep. 30, 2024	Dec. 31, 2022	Sep. 30, 2025	Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services		$ 31	$ 62
Number of warrants						0	10,750,000
Weighted Average Exercise Price of $0.0991
Subsidiary, Sale of Stock [Line Items]
Number of warrants						10,750,000
Weighted average exercise price						$ 0.0991
Common Stock
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services (in shares)		3,613,000	1,550,000		5,496,000
Issuance of common stock for services					$ 400
Common Stock \| Vendor
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services (in shares)				1,549,410
Common Stock \| Strategic Advisory Services
Subsidiary, Sale of Stock [Line Items]
Issuance of common stock for services (in shares)	3,613,013